Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

3.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.9K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

421
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
421
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

76
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
76

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease progression and economic burden of duchenne muscular dystrophy: A retrospective study using Swedish register data.

Journal of neuromuscular diseases·2026
Same author

Relationship between Dermatology Life Quality Index Scores and EQ-5D-5L Utility Values in Adults with Atopic Dermatitis: Development of a Swedish Mapping Model.

Acta dermato-venereologica·2026
Same author

Understanding Patient and Gastroenterologist Preferences at the Time of Treatment Escalation to First-Line Advanced Therapy in Ulcerative Colitis: A Discrete Choice Experiment in Five European Countries.

United European gastroenterology journal·2026
Same author

Risk of hidradenitis suppurativa in patients with juvenile arthritis: A nationwide cohort study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Dupilumab-Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib.

Pediatric dermatology·2026
Same author

The hazards of using hazard ratios from proportional hazard models in indirect treatment comparisons.

Research synthesis methods·2026

Related Experiment Video

Updated: Jul 13, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.2K

Comorbidities in childhood atopic dermatitis: A population-based study.

Laura von Kobyletzki1, Dan Henrohn2,3, Natalia Ballardini4,5,6

  • 1Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Lund, Sweden.

Journal of the European Academy of Dermatology and Venereology : JEADV
|October 12, 2023
PubMed
Summary

Children with atopic dermatitis (AD) face a significantly higher risk of developing various comorbidities, including allergic disorders and malignancies. This risk increases with AD severity, highlighting the substantial clinical burden.

More Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

10.4K
Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

9.7K

Related Experiment Videos

Last Updated: Jul 13, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.2K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

10.4K
Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

9.7K

Area of Science:

  • Dermatology
  • Pediatric Health
  • Epidemiology

Background:

  • Atopic dermatitis (AD) is a chronic inflammatory skin condition often linked to allergic issues.
  • Existing research on comorbidities in childhood AD is limited, potentially impacting patient care.
  • Understanding these associations is crucial for comprehensive management of pediatric AD.

Purpose of the Study:

  • To investigate and compare the incidence of allergic and non-allergic comorbidities in children diagnosed with AD versus a matched control group.
  • To analyze the association between AD severity and the risk of developing comorbid conditions.
  • To provide a comprehensive overview of the comorbidity landscape in pediatric AD.

Main Methods:

  • A nationwide population-based cohort study utilizing longitudinal Swedish healthcare registers.
  • Identification of patients with AD through confirmed diagnoses in primary or specialist care.
  • Matching of an AD cohort (n=165,145) with a non-AD reference cohort (n=165,145) for comparative risk analysis.

Main Results:

  • Children with AD exhibited a higher risk for all evaluated comorbidity categories, excluding Type 1 diabetes and skeletal disorders, compared to controls.
  • The most pronounced increased risks were observed for hypersensitivity/allergic disorders (HR: 3.87), malignancies (HR: 2.53), and immunological/inflammatory disorders (HR: 2.36).
  • Increased AD severity and active disease were associated with a greater risk of comorbidity onset.

Conclusions:

  • The clinical impact of atopic dermatitis in children is significant, with elevated risks for numerous comorbidities beyond the typical 'atopic march'.
  • A clear positive correlation exists between increasing AD severity and the likelihood of developing comorbid conditions.
  • These findings underscore the need for vigilant monitoring and management of comorbidities in pediatric AD patients.